Pfizer expands access to the Covid pill. Following the path already taken by Merck, the pharmaceutical giant signs a licensing agreement with the UN-backed Medicines Patent Pool to expand access to its antiviral pill in developing countries. Agreement to increase supplies of Pfizer’s anti-viral pills. In fact, generic drug manufacturers will be able to produce the drug in advance of the authorities’ green light to speed up supplies to low- and middle-income countries. The agreement is the first with which the company opens to the sharing of technology on an anti Covid product.
breaking latest news © Copyright ANSA